sameAs
Comparing selection on S. aureus between antimicrobial peptides and common antibioticsEvidence for potential functionality of nuclearly-encoded humanin isoforms.Structural characterization and antimicrobial activity of the Zn(II) complex with P113 (demegen), a derivative of histatin 5.Effect of cryogrinding on chemical stability of the sparingly water-soluble drug furosemideCoordination of Ni2+ and Cu2+ to metal ion binding domains of E. coli SlyD protein.Potential therapeutic role of cationic peptides in three experimental models of septic shock.The hypoxia-inducible miR-429 regulates hypoxia-inducible factor-1α expression in human endothelial cells through a negative feedback loop.Kinin release from human kininogen by 10 aspartic proteases produced by pathogenic yeast Candida albicansSearching for new strategies against biofilm infections: Colistin-AMP combinations against Pseudomonas aeruginosa and Staphylococcus aureus single- and double-species biofilms.miR-429 regulates the transition between Hypoxia-Inducible Factor (HIF)1A and HIF3A expression in human endothelial cells.Temporin A soaking in combination with intraperitoneal linezolid prevents vascular graft infection in a subcutaneous rat pouch model of infection with Staphylococcus epidermidis with intermediate resistance to glycopeptidesThe Antistaphylococcal Activity of Citropin 1.1 and Temporin A against Planktonic Cells and Biofilms Formed by Isolates from Patients with Atopic Dermatitis: An Assessment of Their Potential to Induce Microbial Resistance Compared to Conventional AnCationic Net Charge and Counter Ion Type as Antimicrobial Activity Determinant Factors of Short LipopeptidesActivity of antimicrobial peptides, alone or combined with conventional antibiotics, against Staphylococcus aureus isolated from the airways of cystic fibrosis patients.Bioelectronic nose: Current status and perspectives.Novel orally available salvinorin A analog PR-38 inhibits gastrointestinal motility and reduces abdominal pain in mouse models mimicking irritable bowel syndrome.Secreted trypanosome cyclophilin inactivates lytic insect defense peptides and induces parasite calcineurin activation and infectivityLipopeptide Laur-CKK-NH2 dimer preserves daptomycin susceptibility and enhances its activity against Enterococcus faecalis.Antimicrobial peptide-induced apoptotic death of leishmania results from calcium-de pend ent, caspase-independent mitochondrial toxicityInfluence of Amphibian Antimicrobial Peptides and Short Lipopeptides on Bacterial Biofilms Formed on Contact Lenses.Comparative Study on Antistaphylococcal Activity of Lipopeptides in Various Culture Media.A novel mechanism of action of the fumagillin analog, TNP-470, in the B16F10 murine melanoma cell line.Effects of pexiganan alone and combined with betalactams in experimental endotoxic shock.Capping Agent-Dependent Toxicity and Antimicrobial Activity of Silver Nanoparticles: An In Vitro Study. Concerns about Potential Application in Dental Practice.Inactivation of human kininogen-derived antimicrobial peptides by secreted aspartic proteases produced by the pathogenic yeast Candida albicans.Co-immobilization of Palm and DNase I for the development of an effective anti-infective coating for catheter surfaces.Rapid Screening of Antimicrobial Synthetic PeptidesEfficacy of the combination of tachyplesin III and clarithromycin in rat models of Escherichia coli sepsis.In vitro activity of aurein 1.2 alone and in combination with antibiotics against gram-positive nosocomial cocci.Efficacy of tachyplesin III, colistin, and imipenem against a multiresistant Pseudomonas aeruginosa strain.In vitro activity and in vivo animal model efficacy of IB-367 alone and in combination with imipenem and colistin against Gram-negative bacteria.Administration of protegrin peptide IB-367 to prevent endotoxin induced mortality in bile duct ligated rats.IB-367 pre-treatment improves the in vivo efficacy of teicoplanin and daptomycin in an animal model of wounds infected with meticillin-resistant Staphylococcus aureus.Release of biologically active kinin peptides, Met-Lys-bradykinin and Leu-Met-Lys-bradykinin from human kininogens by two major secreted aspartic proteases of Candida parapsilosis.N-Alkyl derivatives of diosgenyl 2-amino-2-deoxy-β-D-glucopyranoside; synthesis and antimicrobial activity.The role of Glycyrrhizin, an inhibitor of HMGB1 protein, in anticancer therapy.Competition between histamine-like and poly-imidazole coordination sites for Cu(2+) and Zn(2+) ions in zebra-fish peptide of prion-like protein.In vitro activity and killing effect of uperin 3.6 against gram-positive cocci isolated from immunocompromised patients.The C terminus of HspA--a potential target for native Ni(II) and Bi(III) anti-ulcer drugs.The antifungal activity of the cuticular and internal fatty acid methyl esters and alcohols in Calliphora vomitoria.
P50
Q28534528-A29AB5F8-9F90-47BB-92A1-7CBBD49D0533Q29871493-77D5256C-4FFB-4AA5-B74A-FA2BFDF06EBDQ33683696-655349F5-E236-443B-8702-766CD2842C7BQ33943384-87E70A4A-BBC4-45B2-9663-C06499C50ADDQ34104516-70F57080-6D38-4345-AC1F-B1D3CBC4C376Q34109677-AF9719F5-DC5C-4F9F-8E15-544FCB938F89Q35410718-79B5F2B5-BB0A-473A-9149-3DDA9BF93215Q35603104-A790D182-3581-4DC2-9BD7-ACEF460E9845Q36326740-0C0C3FD6-01F5-46C7-A25C-56CEFEDC4369Q36661786-66F4B5AB-B149-4446-9DA8-4F3D9E8F0AE8Q36669700-5F3D39BC-0B68-4B1A-A2CD-55BDEC39DA96Q37064028-935DFA41-B66B-4768-AAFF-36D84352E76CQ37617414-0EEEB47D-0CDE-470C-A202-B9DFAC9330C3Q37705410-E003B51D-1386-486F-BC61-CFD4C01B070DQ38945802-A2D14565-8BCD-4B63-936D-55D7D5300EF3Q39181583-3D9BE0AE-E61E-4D4F-8450-1B27A1A6F598Q39198765-6F227CA8-B7B5-4E2F-9157-6F54B5A297C7Q39773341-11D0B59E-6304-4E7D-8B50-31BD8BA89BA9Q39862605-CAA80323-FCAF-460F-81F6-EB984BE1DBEAQ40107948-DC392EC1-A46F-4438-AEB4-497B566C1BECQ40110084-1A3A6D74-060A-412D-B3FD-173056EF753BQ40386115-A0606255-28F3-409E-9C34-45E187877A64Q40457245-F1A0901D-2AEB-4CC0-A91F-4BFD47D5BA8DQ40495119-CCB02AA5-3BB7-4661-871B-B896DCFBDA9CQ40560073-9CCB9457-82E0-4DB3-B80B-73CEBE5B7F87Q40579667-28E88618-CC0D-4044-A4EA-E893217D209EQ40935440-CF6CF43D-F60F-4E5F-BF40-C81C36AF83C8Q41389990-34BE4A13-4A28-4668-8F5F-8ABC49A7781CQ41961948-D1F71A0A-B42A-4B94-962E-6D95387F0E79Q42021167-7449231A-DF66-47D7-9ACB-8CE53652C746Q42228223-1A193083-56D1-4856-9A11-B361640608A2Q42244876-5E80EE91-9975-4240-969D-38273D723BBCQ42256899-A1EFFA47-300D-4CB6-B9D6-BDA114C4E25EQ42443309-9E29EE82-9F8B-4A42-85E5-F007CEE3E148Q42525797-0E017F90-4870-4421-B7C0-2C00E8206448Q42831339-EF12F6BC-C3E2-46EC-94B7-54E3AC19413AQ42935682-627245F2-9ED7-4752-AAC4-092DCCE59935Q42948091-C9451FA9-A706-4E3B-964C-6C5CEC82DC9EQ43054235-C300D493-4409-487C-8741-A507E6BA9119Q43450356-5C0A9823-2D1D-494A-AF95-3C81F1960940
P50
description
Polish chemist
@en
Polish chemist
@en-ca
Polish chemist
@en-gb
Poola keemik
@et
Pools scheikundige
@nl
ceimiceoir Polannach
@ga
chimist polonez
@ro
chimiste polonais
@fr
kimist polak
@sq
polnischer Chemiker
@de
name
Wojciech Kamysz
@af
Wojciech Kamysz
@an
Wojciech Kamysz
@ast
Wojciech Kamysz
@bar
Wojciech Kamysz
@br
Wojciech Kamysz
@bs
Wojciech Kamysz
@ca
Wojciech Kamysz
@co
Wojciech Kamysz
@cs
Wojciech Kamysz
@cy
type
label
Wojciech Kamysz
@af
Wojciech Kamysz
@an
Wojciech Kamysz
@ast
Wojciech Kamysz
@bar
Wojciech Kamysz
@br
Wojciech Kamysz
@bs
Wojciech Kamysz
@ca
Wojciech Kamysz
@co
Wojciech Kamysz
@cs
Wojciech Kamysz
@cy
prefLabel
Wojciech Kamysz
@af
Wojciech Kamysz
@an
Wojciech Kamysz
@ast
Wojciech Kamysz
@bar
Wojciech Kamysz
@br
Wojciech Kamysz
@bs
Wojciech Kamysz
@ca
Wojciech Kamysz
@co
Wojciech Kamysz
@cs
Wojciech Kamysz
@cy
P106
P214
P1153
6602694653
P1207
n2003067967
P1412
P1559
Wojciech Kamysz
@pl
P19
P21
P213
0000 0001 1340 4256
P214
P27
P31
P3124
P496
0000-0001-5335-3043
P569
1975-01-01T00:00:00Z
P734
P735
P7859
viaf-165618012